Showing results (351-360 of 470) with videos related to
Sort By:
Pageof 47
Tumori|March 1, 1975
[Study of the retroperitoneal lymphatic spread of müllerian ovarian carcinoma, using lymphography]R Musumeci, A Banfi, G B Candiani, et al.American Journal of Clinical Oncology|August 24, 2000
Long-acting depot lanreotide in the treatment of patients with advanced neuroendocrine tumorsS Ricci, A Antonuzzo, L Galli, et al.Acta Obstetricia Et Gynecologica Scandinavica|February 1, 1992
Steroid hormones and gonadotropins in a case of ovarian endometriosis associated with virilizationD Mango, P Manna, M Liberati, et al.Frontiers in Veterinary Science|June 8, 2026
Characterization of fecal bacterial microbiomes according to fecal color, consistency, and sample type in piglets before and after weaningC Vaggi, J C Vötterl, F Lerch, et al.Pediatric Surgery International|November 10, 2014
Inguinal hernia in neonates and ex-preterm: complications, timing and need for routine contralateral explorationA Pini Prato, V Rossi, M Mosconi, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 26, 2013
Overall survival for sorafenib plus interleukin-2 compared with sorafenib alone in metastatic renal cell carcinoma (mRCC): final results of the ROSORC trialG Procopio, E Verzoni, S Bracarda, et al.La Clinica Terapeutica|February 28, 2017
Psychopathology and neoplastic disease: medico-social and medico-legal considerationsF Massoni, P Ricci, M Crusco, et al.Journal of Pediatric Urology|November 15, 2017
Hydronephrosis and crossing vessels in children: Optimization of diagnostic-therapeutic pathway and analysis of color Doppler ultrasound and magnetic resonance urography diagnostic accuracyM C Y Wong, G Piaggio, M B Damasio, et al.Pediatric Surgery International|March 23, 2010
Genomics approach to the analysis of bacterial communities dynamics in Hirschsprung's disease-associated enterocolitis: a pilot studyC De Filippo, A Pini-Prato, G Mattioli, et al.British Journal of Cancer|March 31, 2011
Sorafenib with interleukin-2 vs sorafenib alone in metastatic renal cell carcinoma: the ROSORC trialG Procopio, E Verzoni, S Bracarda, et al.Pageof 47